Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant. - Wikidata - awgldk - TriplyDB

Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant.

Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant.

http://www.wikidata.org/entity/Q40599120

about

Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome Recently published papers: inflammation, elucidation, manipulation?Pediatric Acute Respiratory Distress Syndrome: Fibrosis versus Repair Acute lung failure The Role of Surfactant in Lung Disease and Host Defense against Pulmonary Infections Surfactant for pediatric acute lung injury Surfactant therapy for acute lung injury and acute respiratory distress syndrome.Aerosolised surfactant generated by a novel noninvasive apparatus reduced acute lung injury in rats Computed tomography assessment of exogenous surfactant-induced lung reaeration in patients with acute lung injury Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysis.Acute respiratory distress syndrome: A clinical review Critical care medicine in AJRCCM 2003.Pediatrics, surfactant, and cystic fibrosis in AJRCCM 2003.Pediatric acute hypoxemic respiratory failure: management of oxygenation.Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration.Evolution of treatments for patients with acute lung injury.Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids.Exogenous surfactant therapy for ARDS.Current concepts on the pulmonary surfactant in infants.Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome.New synthetic surfactant - how and when?Effective inhaled drug administration to mechanically ventilated patients.Nonventilatory treatments for acute lung injury and ARDS.Surfactant therapy for acute respiratory failure in children: a systematic review and meta-analysis Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome--where do we go from here?Nonventilatory interventions in the acute respiratory distress syndrome.Pharmacotherapy of acute lung injury and acute respiratory distress syndrome Acute respiratory distress syndrome: a historical perspective.Delivery and performance of surfactant replacement therapies to treat pulmonary disorders.Investigation of surfactant protein-D and interleukin-6 levels in patients with blunt chest trauma with multiple rib fractures and pulmonary contusions: a cross-sectional study in Black Sea Region of Turkey.Predictive modeling and inflammatory biomarkers in rats with lung contusion and gastric aspiration.Exogenous pulmonary surfactant for acute respiratory distress syndrome in adults: A systematic review and meta-analysis.Gas exchange in the respiratory distress syndromes.Overcoming inactivation of the lung surfactant by serum proteins: a potential role for fluorocarbons?Surfactant administration in severe inhalation injury: case report.Surfactants in Acute Respiratory Distress Syndrome in Infants and Children: Past, Present and Future.Development of a Synthetic Surfactant Using a Surfactant Protein-C Peptide Analog: In Vitro Studies of Surface Physical Properties.The clinical practice guideline for the management of ARDS in Japan.Adjusting tidal volume to stress index in an open lung condition optimizes ventilation and prevents overdistension in an experimental model of lung injury and reduced chest wall compliance.Protective effects of elevated endogenous surfactant pools to injurious mechanical ventilation.

P2860

Q24246217-4F38EF65-119D-45B3-83AC-533D279C3E1F Q24795629-DD949260-AC72-422F-972E-AC3C998EC170 Q26749366-A91E87AB-EFA1-474B-A0DE-C4D8097A831F Q26852173-F230DD43-21E2-437C-BA43-720E0EE9E985 Q26865690-6FFE5F02-E249-44CF-80F1-5CBFF0F3FB73 Q30409008-B745FD06-21C6-402A-A7D8-A794D0A7D1D2 Q30426177-A0E7A449-69A8-4403-84BF-41DE6F5E3142 Q33414437-5C32F05D-5251-4699-AE42-45B533937EFE Q34153241-5087C041-0D4D-4923-965D-A070D895B8DA Q34999391-381B5694-A839-48F8-842F-13E50054F639 Q35412409-32720298-528A-461F-8A38-E8C13F7808F7 Q35626606-B6E4A35D-8A70-4440-BAFF-A9C0F8740B07 Q35626617-8E1AB246-C729-4F72-AFE8-75FF444F9DB8 Q35779090-CC816A96-1669-474D-96DF-93DB8F64DCE8 Q35945347-49149B89-D2E2-4ED6-A1B6-9E92D96699BC Q36145843-E94F9E4B-760A-4884-B6BB-22504DB414B5 Q36225820-20AA0C2E-A4B2-4683-B72D-05167C72E324 Q36349649-E0FA2517-DBFF-4FC5-ABF2-6A82EB22632D Q36359561-E444D146-9673-4F9B-A075-47F512ED757C Q36467694-9D8C044C-3946-4DAA-A1DB-426D3680C20C Q36504555-F7DF0A3C-D32F-485F-AE0D-E43A485629EB Q36690213-879478D3-F680-4DE0-9D18-EEEF8C653837 Q36758874-8ABC7B9D-9851-4E43-A84F-27D2B4F16738 Q36851206-18694CAD-1A4E-4EFF-A13D-38CC795EFC96 Q36902581-D03C3013-8922-453E-94E6-BA79F146E3EE Q37071344-459F8FA0-3F98-46DF-90C7-31C311215655 Q37085611-E782AC16-5882-4287-8317-43E8E5197A3D Q37282570-155D2F41-8A09-4A5E-AAA1-081E7978B219 Q37341712-CB0C2694-114B-45C0-9BE7-2282ED30D429 Q37356227-713EDAE4-0A68-4E4A-9F9D-AE41A03F9DA8 Q37486406-CB2E6505-9806-4F8C-9D4B-636E40C31C9A Q38068408-3C5936D2-504A-44CD-B21A-DFCD581B3966 Q38110743-9FBF7676-3F88-495E-A381-18BEF01BFEE6 Q38537738-FEF628D7-3674-4549-9F69-707B6E64D466 Q38638746-842EDA69-2D48-46D6-83A8-275981CD5229 Q38683183-37098E2C-4BAF-4923-9678-5C543D9FAC87 Q40246941-4D894089-0EF6-4641-918E-4821CCDD34A3 Q41117178-4FFDDC74-D689-4085-87C6-B82AC2AA3B75 Q41590592-885DDC74-6D33-4F66-9AA4-E87CCE840D25 Q46788993-34057C3F-ABEB-426C-9423-77E3E393A0C6

P2860

Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant.

http://www.wikidata.org/entity/Q40599120

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Treatment of acute respiratory ...... rfactant protein C surfactant.

@en

type

label

Treatment of acute respiratory ...... rfactant protein C surfactant.

@en

prefLabel

Treatment of acute respiratory ...... rfactant protein C surfactant.

@en

P1433

Q40599120-9163E399-50E2-44E9-A340-8883EEFC05E6

P1476

Q40599120-0E84379C-A0B9-4DA1-8602-6213ED05E358

P2093

Q40599120-5BE0013F-70D7-493C-A03A-24F14B5E0839

Q40599120-68630A04-8A65-412A-A899-55245FDC8752

Q40599120-73EF2156-EDB3-4C75-92EE-C8556469845D

Q40599120-78C2146B-04B8-4FF2-B5CA-7125D914F622

Q40599120-92EB64DA-3984-4B96-AB8A-5BB04A93772F

Q40599120-D8F34AEC-833E-4724-9B3B-8112D3107155

Q40599120-DDED4B51-1DAE-4155-9E14-FC26B085495E

P2860

Q40599120-068E29F1-9FCB-4693-86BC-5C7CD4774F61

Q40599120-07A1E703-6466-4315-B504-709E3950A8E8

Q40599120-09075AE7-8AE1-4DF3-BBBE-3BEEFABEBD05

Q40599120-0ECAEE95-2845-4DE2-8AD6-93A3359A47C8

Q40599120-164DF901-2159-487A-86A4-EFB2AFE73F94

Q40599120-2A72A397-2712-4F81-9554-5D262075D8DF

Q40599120-34CC3719-B577-4015-B243-D5381BEDF0B9

Q40599120-4ECE764E-C2A7-457D-8B94-73B4D167D21F

Q40599120-53A0EF17-D23B-4CC0-BAB4-6F9F7FE30D09

Q40599120-605F0D40-A828-40D5-B9F8-6B01A3B1F3AC

P304

Q40599120-236EA774-8C20-427E-A4C7-E249C4D85A6B

P31

Q40599120-C315C196-11A7-4341-A884-905D187F5D69

P356

Q40599120-0D42DECB-5C26-4100-9C0E-4955BCC97458

P407

Q40599120-57A2E2F9-38E9-46E8-B8C2-CCE88F043598

P433

Q40599120-39E72790-D877-4FE7-8236-CF1807C9E96A

P478

Q40599120-9A74011D-4719-4EDB-B715-C9F44FB98DD0

P577

Q40599120-6AD3DDED-4BAA-4021-B009-CD1EC3E30BBC

P698

Q40599120-055009A9-6DCE-4D89-8056-743EC59F886E

P921

Q40599120-2F0D7F10-8403-458A-B7F2-47822BE148D9

P356

RCCM.200207-782OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Treatment of acute respiratory ...... rfactant protein C surfactant.

@en

P2093

Dietrich Häfner

http://www.w3.org/2001/XMLSchema#string

James F Lewis

http://www.w3.org/2001/XMLSchema#string

James J Marsh

http://www.w3.org/2001/XMLSchema#string

Mark D Wewers

http://www.w3.org/2001/XMLSchema#string

Robert P Baughman

http://www.w3.org/2001/XMLSchema#string

Roger G Spragg

http://www.w3.org/2001/XMLSchema#string

Wilhelm Wurst

http://www.w3.org/2001/XMLSchema#string

P2860

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network

Surfactant Proteins A and D and Pulmonary Host Defense

Calf's lung surfactant extract in acute hypoxemic respiratory failure in children.

Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome.

Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol

Increases in allergen-specific IgE in BAL after segmental allergen challenge in atopic asthmatics.

Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial.

Surfactant and the adult respiratory distress syndrome.

Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia.

Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS).

P304

1562-1566

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.200207-782OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

167

http://www.w3.org/2001/XMLSchema#string

P577

2003-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12649125

http://www.w3.org/2001/XMLSchema#string

P921

acute respiratory distress syndrome